AP NEWS

Osteonecrosis Pipeline Review: H1 2018 - Therapeutics Development & Assessment, Companies Involved, and Drug Profiles Covered - ResearchAndMarkets.com

June 11, 2018

DUBLIN--(BUSINESS WIRE)--Jun 11, 2018--The “Osteonecrosis - Pipeline Review, H1 2018” report has been added to ResearchAndMarkets.com’s offering.

This latest pipeline guide provides comprehensive information on the therapeutics under development for Osteonecrosis (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Osteonecrosis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteonecrosis and features dormant and discontinued projects.

The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Phase III, Phase II and Preclinical stages are 1, 1 and 3 respectively.

Companies Mentioned

Bone Therapeutics SA Enzo Biochem Inc K-Stemcell Co Ltd

Key Topics Covered

Introduction Report Coverage Osteonecrosis - Overview Osteonecrosis - Therapeutics Development Pipeline Overview Pipeline by Companies Products under Development by Companies Osteonecrosis - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Osteonecrosis - Companies Involved in Therapeutics Development Osteonecrosis - Drug Profiles

For more information about this report visit https://www.researchandmarkets.com/research/w6zcdq/osteonecrosis?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180611005897/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Musculoskeletal Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/11/2018 12:50 PM/DISC: 06/11/2018 12:51 PM

http://www.businesswire.com/news/home/20180611005897/en

AP RADIO
Update hourly